ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,498Medicare Part D Prescriptions Filled, Including Refills

Rank: 169 out of 2429

$591K Total Retail Price of All Prescriptions

Rank: 188 out of 2429

305 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 305 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

0% of this provider’s 8,087 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LEVOTHYROXINE SODIUM 524 401 1 3
NAMENDA 443 427 2 35
SIMVASTATIN 428 207 3 1
OMEPRAZOLE 394 275 4 7
AMLODIPINE BESYLATE 386 276 5 4
LISINOPRIL 335 216 6 2
DONEPEZIL HCL 319 319 7 26
CITALOPRAM HBR 261 243 8 19
METOPROLOL TARTRATE 256 187 9 9
FUROSEMIDE 203 176 10 5
DIVALPROEX SODIUM 202 125 11 78
ESCITALOPRAM OXALATE 198 180 12 74
WARFARIN SODIUM 185 185 13 11
QUETIAPINE FUMARATE 169 151 14 77
RISPERIDONE 168 141 15 52
HYDROCHLOROTHIAZIDE 162 114 16 10
METOPROLOL SUCCINATE 155 111 17 12
METFORMIN HCL 155 69 17 8
SERTRALINE HCL 154 146 19 23
TRAZODONE HCL 154 154 19 50
MIRTAZAPINE 145 141 21 63
OXYBUTYNIN CHLORIDE ER 134 67 22 79
TAMSULOSIN HCL 133 60 23 29
POLYETHYLENE GLYCOL 3350 125 97 24 56
ALENDRONATE SODIUM 109 80 25 20
ATORVASTATIN CALCIUM 98 61 26 13
LEVETIRACETAM 95 22 27 91
ATENOLOL 89 45 28 15
EXELON 86 86 29 132
LOVAZA 81 0 30 134
PRAVASTATIN SODIUM 75 75 31 16
ENALAPRIL MALEATE 74 23 32 32
DIGOXIN 72 72 33 43
CARBIDOPA-LEVODOPA 72 72 33 88
POTASSIUM CHLORIDE 70 67 35 14
CLOPIDOGREL 69 47 36 31
LEVOXYL 64 15 37 246
LOVASTATIN 62 27 38 30
FLUTICASONE PROPIONATE 62 11 38 39
ABILIFY 62 44 38 121
CARVEDILOL 61 48 41 21
SPIRONOLACTONE 60 50 42 62
GALANTAMINE HBR 58 54 43 375
PHENYTOIN SODIUM EXTENDED 57 23 44 108
HYDROCODONE-ACETAMINOPHEN 56 54 S3 45 6
BUSPIRONE HCL 56 56 45 160
LAMOTRIGINE 55 0 47 130
LEVOFLOXACIN 55 51 47 87
GABAPENTIN 55 46 47 18
SEROQUEL 53 40 50 169
CLOTRIMAZOLE-BETAMETHASONE 53 34 50 181
METOCLOPRAMIDE HCL 52 0 52 112
HYDRALAZINE HCL 51 51 53 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 22, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.